Tetrahydrobiopterin restores endothelial function in hypercholesterolemia.

由 Stroes, E, Kastelein, J, Cosentino, F, Erkelens, W, Wever, R, Koomans, H, Lüscher, T, Rabelink, T
出版 1997

Increased systemic and plaque inflammation in ABCA1 mutation carriers with attenuation by statins

由 Bochem, A.E., van der Valk, F.M., Tolani, S., Stroes, E.S., Westerterp, M., Tall, A.R.
發表在 Arterioscler Thromb Vasc Biol (2015)

Triglycerides and Cardiovascular Risk

由 Harchaoui, K.E.L, Visser, M.E, Kastelein, J.J.P, Stroes, E.S, Dallinga-Thie, G.M
出版 2009

Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPARγ mutation (Y151C)

由 Visser, M. E., Kropman, E., Kranendonk, M. E., Koppen, A., Hamers, N., Stroes, E. S., Kalkhoven, E., Monajemi, H.
出版 2011

Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis

由 Wijbrandts, C A, van Leuven, S I, Boom, H D, Gerlag, D M, Stroes, E G S, Kastelein, J J P, Tak, P P
出版 2008

Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia

由 Visser, M. E., Lammers, N. M., Nederveen, A. J., van der Graaf, M., Heerschap, A., Ackermans, M. T., Sauerwein, H. P., Stroes, E. S., Serlie, M. J.
出版 2011

Inhibition of hepatic Sulf2 in vivo: a novel strategy to correct diabetic dyslipidemia

由 Hassing, H.C., Mooij, H., Guo, S., Monia, B.P., Chen, Keyang, Kulik, W., Dallinga-Thie, G.M., Nieuwdorp, M., Stroes, E.S.G., Williams, K.J.
出版 2012

Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus

由 Broekhuizen, L. N., Lemkes, B. A., Mooij, H. L., Meuwese, M. C., Verberne, H., Holleman, F., Schlingemann, R. O., Nieuwdorp, M., Stroes, E. S. G., Vink, H.
出版 2010

Reconstituted HDL infusion restores endothelial function in patients with type 2 diabetes mellitus

由 Nieuwdorp, M., Vergeer, M., Bisoendial, R. J., op ‘t Roodt, J., Levels, H., Birjmohun, R. S., Kuivenhoven, J. A., Basser, R., Rabelink, T. J., Kastelein, J. J. P., Stroes, E. S. G.
出版 2008

Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low LDL-C levels in a primary prevention setting

由 Verbeek, R., Hoogeveen, R.M., Langsted, A., Stiekema, L.C.A., Verweij, S.L., Hovingh, G.K, Wareham, N.J., Khaw, K-T, Boekholdt, S.M., Nordestgaard, B.G., Stroes, E.S.G.
發表在 Eur Heart J (2018)

Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis

由 Nieuwdorp, M., Holleman, F., de Groot, E., Vink, H., Gort, J., Kontush, A., Chapman, M. J., Hutten, B. A., Brouwer, C. B., Hoekstra, J. B. L., Kastelein, J. J. P., Stroes, E. S. G.
出版 2007

Apolipoprotein C-III levels and Incident Coronary Artery Disease Risk: The EPIC-Norfolk Prospective Population Study

由 van Capelleveen, J.C., Moens, S.J. Bernelot, Yang, X., Kastelein, J.J.P., Wareham, N.J., Zwinderman, A.H., Stroes, E.S.G., Witztum, J.L., Hovingh, G.K., Khaw, K.T., Boekholdt, S.M., Tsimikas, S.
發表在 Arterioscler Thromb Vasc Biol (2017)

Loss of Function in Heparan Sulfate Elongation Genes EXT1 and EXT 2 Results in Improved Nitric Oxide Bioavailability and Endothelial Function

由 Mooij, H. L., Cabrales, P., Bernelot Moens, S. J., Xu, D., Udayappan, S. D., Tsai, A. G., van der Sande, M. A. J., de Groot, E., Intaglietta, M., Kastelein, J. J. P., Dallinga‐Thie, G. M., Esko, J. D., Stroes, E. S., Nieuwdorp, M.
發表在 J Am Heart Assoc (2014)